25 companies

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products.

CLN

zł21.10

7D

7.1%

1Y

-12.1%

Selvita

Market Cap: zł550.7m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł29.60

7D

-2.0%

1Y

-6.9%

Bioceltix

Market Cap: zł517.3m

Engages in the development of veterinary biologics based on mesenchymal stem cells.

BCX

zł92.60

7D

2.0%

1Y

-11.8%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł475.9m

A biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland.

CTX

zł75.30

7D

-0.1%

1Y

82.3%

Ryvu Therapeutics

Market Cap: zł346.3m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł14.90

7D

-2.7%

1Y

-52.8%

BIOTON

Market Cap: zł329.3m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO

zł3.82

7D

-0.4%

1Y

-8.3%

Synthaverse

Market Cap: zł206.1m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

SVE

zł2.75

7D

0%

1Y

-46.1%

Mabion

Market Cap: zł123.2m

A biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.

MAB

zł7.86

7D

6.5%

1Y

-17.3%

Molecure

Market Cap: zł120.3m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

MOC

zł5.80

7D

-2.0%

1Y

1.0%

Poltreg

Market Cap: zł116.6m

A biotechnology company, researches and develops therapies for autoimmune diseases.

PTG

zł19.60

7D

2.3%

1Y

-38.4%

NanoGroup

Market Cap: zł107.2m

Operates as a biotechnology company in Poland.

NNG

zł2.51

7D

0.4%

1Y

-4.7%

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

HEN

zł2.32

7D

0%

1Y

-34.6%

Urteste

Market Cap: zł73.3m

Engages in the research and development of diagnostic tests for cancers.

URT

zł47.00

7D

-2.5%

1Y

-4.3%

Genomtec

Market Cap: zł70.7m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł4.63

7D

-1.5%

1Y

-27.5%

Read-Gene

Market Cap: zł56.8m

Engages in the detection, prevention, and treatment of various types of cancer.

RDG

zł4.60

7D

-1.1%

1Y

-11.5%

Biogened

Market Cap: zł45.2m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.50

7D

0%

1Y

-32.5%

Genomed Spólka Akcyjna

Market Cap: zł35.9m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł27.60

7D

-5.5%

1Y

7.0%

Medicofarma Biotech

Market Cap: zł28.0m

Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

MDB

zł0.41

7D

-1.9%

1Y

34.6%

Pure Biologics

Market Cap: zł26.4m

A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

PUR

zł2.11

7D

-1.9%

1Y

-65.4%

genXone

Market Cap: zł19.0m

Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.

GX1

zł5.74

7D

-4.7%

1Y

-0.7%

Stem Cells Spin

Market Cap: zł16.9m

Operates as a biotechnology company in Poland.

SCS

zł0.50

7D

33.7%

1Y

89.4%

Green Zebras Spolka Akcyjna

Market Cap: zł14.9m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

GRZ

zł9.50

7D

4.4%

1Y

8.0%

Cannabis Poland

Market Cap: zł13.4m

Operates in the medical cannabis industry in Poland.

CBD

zł0.18

7D

-2.7%

1Y

-47.0%

Tecnovatica

Market Cap: zł5.7m

Does not have significant operations.

TEC

zł0.53

7D

3.5%

1Y

26.9%

Labocanna

Market Cap: zł4.6m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.22

7D

-1.4%

1Y

-30.3%